Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.

Gunter Almer (First author)
, D Frascione
, I Pali-Schoell
, C Vonach
, A Lukschal
, C Stremitzer
, SC Diesner
, E Jensen-Jarolim
, Ruth Prassl
, Harald Mangge^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Research article

49 Citations (Web of Science)

Original language	English
Journal	Molecular Pharmaceutics
DOIs	https://doi.org/10.1021/mp300316n
Publication status	Published - 2013

Branches of science

104 Chemistry
106 Biology
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine
305 Other Human Medicine, Health Sciences

DOI

10.1021/mp300316n

Links

Cite this

@article{26d38b49a4fd46b59ef00eb7e8ff6c2b,

title = "Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.",

author = "Gunter Almer and D Frascione and I Pali-Schoell and C Vonach and A Lukschal and C Stremitzer and SC Diesner and E Jensen-Jarolim and Ruth Prassl and Harald Mangge",

year = "2013",

doi = "10.1021/mp300316n",

language = "English",

journal = "Molecular Pharmaceutics",

issn = "1543-8384",

publisher = "American Chemical Society",

}

TY - JOUR

T1 - Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.

AU - Frascione, D

AU - Pali-Schoell, I

AU - Vonach, C

AU - Lukschal, A

AU - Stremitzer, C

AU - Diesner, SC

AU - Jensen-Jarolim, E

AU - Prassl, Ruth

A2 - Almer, Gunter

A2 - Mangge, Harald

PY - 2013

Y1 - 2013

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000313156100019

UR - https://pubmed.ncbi.nlm.nih.gov/23176185

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC3558023

U2 - 10.1021/mp300316n

DO - 10.1021/mp300316n

M3 - Research article

C2 - 23176185

SN - 1543-8384

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

ER -